Diabetes may be independent risk factor for hyperkalaemiaBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7418.812 (Published 02 October 2003) Cite this as: BMJ 2003;327:812
- Paul R Jarman (firstname.lastname@example.org), consultant neurologist,
- Hugh M Mather, consultant in diabetes and endocrinology
- National Hospital for Neurology and Neurosurgery, London WC1N 3BG
- Ealing Hospital, Ealing, Middlesex UB1 3HW
EDITOR—Wrenger et al reported severe hyperkalaemia in patients taking spironolactone in combination with angiotensin converting enzyme inhibitors or angiotensin-II antagonists.1 The strikingly high prevalence of diabetes in these patients (80%) is likely to be important.
In a study of the prevalence of hyperkalaemia in an unselected diabetic outpatient population we found that hyperkalaemia was …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial